New Gastric & Esophageal Cancer Treatment Breakthrough

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.

Current State of Targeted Therapy and Immunotherapy in Advanced

Machine Learning Tool Predicts Forms of Esophageal and Stomach

Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer

Consensus panel recommendations on HER-2 scoring for gastric/esophageal

New Breakthrough May Advance Triple Negative Breast Cancer

New Cancer Treatment: The Hope of Cancer Free World On Its way

Signaling pathways and therapeutic interventions in gastric cancer

Current Oncology, Free Full-Text

Immunotherapy Improves Survival in Advanced Esophageal Cancer - NCI

KEYNOTE-590 study design. * Duration of cisplatin treatment will

New Targeted Treatments Emerge For Gastric and Esophageal Cancer

Frontiers Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in China

Esophageal Cancer Action Network - Esophageal Cancer Action Network